Verona Pharma Plc. (VRNA) NASDAQ

$15.82 (0.09) (-0.57%)

Market Cap: $824.43M

As of 04/15/24 03:59 PM EDT. Market closed.

(VRNA)

Verona Pharma Plc. (VRNA)
NASDAQ

$15.82
(0.09) (-0.57%)

Market Cap: $824.43M

As of 04/15/24 03:59 PM EDT. Market closed.

Add to Portfolio

verona pharma is a clinical stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of respiratory diseases with significant unmet medical needs. we are currently focused on developing our novel lead therapeutic candidate in the treatment of chronic obstructive pulmonary fibrosis (copd) and cystic fibrosis (cf), and may expand our ... read more

verona pharma is a clinical stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of respiratory diseases with significant unmet medical needs. we are currently focused on developing our novel lead therapeutic candidate in the treatment of chronic obstructive pulmonary fibrosis (copd) and cystic fibrosis (cf), and may expand our pipeline to help address the gaps in treatment of other respiratory diseases. we are led by a team with deep industry experience, including extensive backgrounds in the discovery, development and commercialization of respiratory therapies. in addition, we have established relationships with leading research institutions and advocacy organizations in the respiratory space and have received awards in support of our continued work and innovation. verona pharma is listed on the nasdaq global market in the united states under the ticker symbol vrna and on the london stock exchange in the united kin read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Medicinal and Botanical Manufacturing
CEO
David Zaccardelli
Full Time Employees
40
URL
Address
Riverside, London, 3 More London Place, SE1 2RE.
Sector
Manufacturing
Industry
Medicinal and Botanical Manufacturing
CEO
David Zaccardelli
Full Time Employees
40
Address
Riverside, London, 3 More London Place, SE1 2RE.
PRICE CHART FOR VERONA PHARMA PLC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$15.93
Previous Close
$15.91
Days Range
$15.65 - $16.20
52 week range
$11.83 - $23.81
Volume
321,867
Avg. Volume (30 days)
394,967
Market Cap
$824.43M
Dividend Yield
-
P/E
(16.26)
Shares Outstanding
51,818,199
Open
$15.93
Previous Close
$15.91
Days Range
$15.65 - $16.20
52 week range
$11.83 - $23.81
Volume
321,867
Avg. Volume (30 days)
394,967
Market Cap
$824.43M
Dividend Yield
-
P/E
(16.26)
Shares Outstanding
51,818,199
FINANCIAL STATEMENTS FOR VERONA PHARMA PLC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR VERONA PHARMA PLC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
ZACCARDELLI DAVIDPresident and CEOFeb 01, 2024 Option Exercise$2.29480,2001,101,48315,942,592Feb 05, 2024, 06:11 PM
Rickard Kathleen A.Chief Medical OfficerFeb 01, 2024 Option Exercise$2.2972,768166,9152,767,872Feb 05, 2024, 06:11 PM
Rickard Kathleen A.Chief Medical OfficerFeb 05, 2024 Sale$2.2236,24880,5032,731,624Feb 05, 2024, 06:11 PM
Poll ClaireGeneral CounselFeb 01, 2024 Option Exercise$2.29103,408237,1971,740,079Feb 05, 2024, 06:10 PM
Hahn Mark WChief Financial OfficerFeb 01, 2024 Option Exercise$2.29480,6641,102,54715,031,576Feb 05, 2024, 06:09 PM
Edwards MartinDirectorNov 20, 2023 Buy$1.8433,73661,973144,800Nov 22, 2023, 05:09 PM
EBSWORTH DAVID RDirectorNov 06, 2023 Buy$1.98160,000316,080844,643Nov 08, 2023, 04:15 PM
Rickard Kathleen A.Chief Medical OfficerNov 01, 2023 Option Exercise$1.74173,136301,9152,899,392Nov 03, 2023, 08:11 PM
Rickard Kathleen A.Chief Medical OfficerNov 03, 2023 Sale$1.9258,752112,8042,840,640Nov 03, 2023, 08:11 PM
Poll ClaireGeneral CounselNov 01, 2023 Option Exercise$1.74173,904303,2541,843,487Nov 03, 2023, 08:09 PM
ZACCARDELLI DAVIDPresident and CEONov 01, 2023 Option Exercise$1.74809,0081,410,74816,422,792Nov 03, 2023, 08:09 PM
Hahn Mark WChief Financial OfficerNov 01, 2023 Option Exercise$1.74809,0081,410,74815,512,240Nov 03, 2023, 08:08 PM
Rickard Kathleen A.Chief Medical OfficerAug 07, 2023 Sale$2.471,6003,9492,872,528Aug 07, 2023, 09:19 PM
Rickard Kathleen A.Chief Medical OfficerAug 04, 2023 Sale$2.5027,94469,8382,874,128Aug 07, 2023, 09:19 PM
Rickard Kathleen A.Chief Medical OfficerAug 03, 2023 Sale$2.5550,600128,7902,923,920Aug 07, 2023, 09:19 PM
ZACCARDELLI DAVIDPresident and CEOAug 03, 2023 Sale$2.54117,272297,75416,590,416Aug 07, 2023, 09:17 PM
ZACCARDELLI DAVIDPresident and CEOAug 07, 2023 Sale$2.478,61621,26316,431,800Aug 07, 2023, 09:17 PM
ZACCARDELLI DAVIDPresident and CEOAug 04, 2023 Sale$2.50150,000374,88016,440,416Aug 07, 2023, 09:17 PM
Hahn Mark WChief Financial OfficerAug 07, 2023 Sale$2.478,61621,26315,521,248Aug 07, 2023, 09:17 PM
Hahn Mark WChief Financial OfficerAug 04, 2023 Sale$2.50150,000374,88015,529,864Aug 07, 2023, 09:17 PM
Hahn Mark WChief Financial OfficerAug 03, 2023 Sale$2.54117,272297,75415,679,864Aug 07, 2023, 09:17 PM
Poll ClaireGeneral CounselAug 03, 2023 Sale$2.5420,60852,3241,935,231Aug 07, 2023, 09:15 PM
Poll ClaireGeneral CounselAug 07, 2023 Sale$2.471,5123,7311,907,367Aug 07, 2023, 09:15 PM
Poll ClaireGeneral CounselAug 04, 2023 Sale$2.5026,35265,8591,908,879Aug 07, 2023, 09:15 PM
Hahn Mark WChief Financial OfficerAug 02, 2023 Sale$2.5973,704191,11415,797,136Aug 03, 2023, 08:31 PM
Hahn Mark WChief Financial OfficerAug 01, 2023 Sale$2.68105,944283,82415,870,840Aug 03, 2023, 08:31 PM
Poll ClaireGeneral CounselAug 02, 2023 Sale$2.5912,94433,5641,955,839Aug 03, 2023, 08:30 PM
Poll ClaireGeneral CounselAug 01, 2023 Sale$2.6818,60849,8511,968,783Aug 03, 2023, 08:30 PM
ZACCARDELLI DAVIDPresident and CEOAug 02, 2023 Sale$2.5973,704191,11416,707,688Aug 03, 2023, 08:29 PM
ZACCARDELLI DAVIDPresident and CEOAug 01, 2023 Sale$2.68105,944283,82416,781,392Aug 03, 2023, 08:29 PM
Rickard Kathleen A.Chief Medical OfficerAug 02, 2023 Sale$2.5913,72835,5972,952,672Aug 03, 2023, 08:27 PM
Rickard Kathleen A.Chief Medical OfficerAug 01, 2023 Sale$2.6819,73652,8732,966,400Aug 03, 2023, 08:27 PM
ORBIMED ADVISORS LLCDirectorMay 15, 2023 Sale$20.08359,7137,222,4844,123,091May 15, 2023, 06:07 PM
ORBIMED ADVISORS LLCDirectorMay 12, 2023 Sale$21.6443,200934,8484,137,491May 15, 2023, 06:07 PM
ORBIMED ADVISORS LLCDirectorMay 11, 2023 Sale$22.2680,0001,780,8004,180,691May 15, 2023, 06:07 PM
Gupta RishiDirectorMay 12, 2023 Sale$21.6443,200934,8484,137,491May 15, 2023, 06:06 PM
Gupta RishiDirectorMay 11, 2023 Sale$22.2680,0001,780,8004,180,691May 15, 2023, 06:06 PM
Gupta RishiDirectorMay 15, 2023 Sale$20.08359,7137,222,4844,123,091May 15, 2023, 06:06 PM
Poll ClaireGeneral CounselMay 01, 2023 Sale$2.5880,376207,0411,979,063May 03, 2023, 07:49 PM
Rickard Kathleen A.Chief Medical OfficerMay 03, 2023 Sale$2.6528,75276,2422,971,136May 03, 2023, 07:49 PM
Rickard Kathleen A.Chief Medical OfficerMay 01, 2023 Sale$2.5877,424199,4362,999,888May 03, 2023, 07:49 PM
Hahn Mark WChief Financial OfficerMay 01, 2023 Sale$2.58455,5281,173,39515,976,784May 03, 2023, 07:48 PM
ZACCARDELLI DAVIDPresident and CEOMay 01, 2023 Sale$2.58455,5361,173,41516,887,336May 03, 2023, 07:46 PM
Hahn Mark WChief Financial OfficerFeb 01, 2023 Sale$2.56413,1681,056,55316,432,312Feb 03, 2023, 06:19 PM
ZACCARDELLI DAVIDPresident and CEOFeb 01, 2023 Sale$2.56432,9281,107,08317,342,872Feb 03, 2023, 06:18 PM
Rickard Kathleen A.Chief Medical OfficerFeb 02, 2023 Sale$2.5328,75272,6853,077,312Feb 03, 2023, 06:17 PM
Rickard Kathleen A.Chief Medical OfficerFeb 01, 2023 Sale$2.5689,960230,0463,106,064Feb 03, 2023, 06:17 PM
Poll ClaireGeneral CounselFeb 01, 2023 Sale$2.59152,000394,273774,256Feb 03, 2023, 06:15 PM
Poll ClaireGeneral CounselDec 22, 2022 Sale$2.69240,000646,032774,256Dec 27, 2022, 06:50 PM
ORBIMED ADVISORS LLCDirectorDec 23, 2022 Sale$22.842,170,36849,576,60735,294,568Dec 27, 2022, 05:38 PM
ORBIMED ADVISORS LLCDirectorDec 22, 2022 Sale$21.773,969,49686,424,24636,940,592Dec 27, 2022, 05:38 PM
Gupta RishiDirectorDec 23, 2022 Sale$22.842,170,36849,576,60735,294,568Dec 27, 2022, 05:32 PM
Gupta RishiDirectorDec 22, 2022 Sale$21.773,969,49686,424,24636,940,592Dec 27, 2022, 05:32 PM
ZACCARDELLI DAVIDPresident and CEODec 20, 2022 Sale$2.12600,0001,269,60017,775,800Dec 21, 2022, 04:06 PM
Hahn Mark WChief Financial OfficerDec 20, 2022 Sale$2.12600,0001,269,06016,845,480Dec 21, 2022, 04:05 PM
ZACCARDELLI DAVIDPresident and CEONov 01, 2022 Option Exercise$1.60454,856727,77018,408,704Nov 03, 2022, 04:06 PM
ZACCARDELLI DAVIDPresident and CEONov 01, 2022 Sale$1.6732,90455,03518,375,800Nov 03, 2022, 04:06 PM
Rickard Kathleen A.Chief Medical OfficerNov 01, 2022 Option Exercise$1.6056,26490,0223,119,776Nov 03, 2022, 04:05 PM
Rickard Kathleen A.Chief Medical OfficerNov 01, 2022 Sale$1.6428,75247,1253,091,024Nov 03, 2022, 04:05 PM
Hahn Mark WChief Financial OfficerNov 01, 2022 Option Exercise$1.60454,856727,77017,458,640Nov 03, 2022, 04:05 PM
Hahn Mark WChief Financial OfficerNov 01, 2022 Sale$1.6713,16022,01117,445,480Nov 03, 2022, 04:05 PM
Access Industries Holdings LLC10% OwnerAug 15, 2022 Buy$1.314,800,0006,300,00055,911,648Aug 17, 2022, 04:03 PM
ZACCARDELLI DAVIDPresident and CEOAug 09, 2022 Sale$1.75600,0001,050,00015,263,560Aug 11, 2022, 09:46 PM
Hahn Mark WChief Financial OfficerAug 09, 2022 Sale$1.75600,0001,050,00014,313,496Aug 11, 2022, 09:45 PM
ZACCARDELLI DAVIDPresident and CEOAug 01, 2022 Option Exercise$0.67454,864305,89615,896,464Aug 03, 2022, 04:12 PM
ZACCARDELLI DAVIDPresident and CEOAug 01, 2022 Sale$0.7032,90423,02615,863,560Aug 03, 2022, 04:12 PM
Rickard Kathleen A.Chief Medical OfficerAug 01, 2022 Option Exercise$0.6756,43237,9512,404,792Aug 03, 2022, 04:11 PM
Rickard Kathleen A.Chief Medical OfficerAug 02, 2022 Sale$0.7028,75220,2162,376,040Aug 03, 2022, 04:11 PM
Hahn Mark WChief Financial OfficerAug 01, 2022 Option Exercise$0.67454,856305,89114,926,664Aug 03, 2022, 04:10 PM
Hahn Mark WChief Financial OfficerAug 01, 2022 Sale$0.7013,1689,21514,913,496Aug 03, 2022, 04:10 PM
Poll ClaireGeneral CounselAug 01, 2022 Option Exercise$0.6779,89653,7301,763,055Aug 03, 2022, 04:10 PM
ZACCARDELLI DAVIDPresident and CEOMay 03, 2022 Sale$0.5032,90416,30716,351,328May 05, 2022, 07:20 PM
Rickard Kathleen A.Chief Medical OfficerMay 03, 2022 Sale$0.4928,75214,1552,461,224May 05, 2022, 07:19 PM
Hahn Mark WChief Financial OfficerMay 03, 2022 Sale$0.5012,5126,20115,381,520May 05, 2022, 07:18 PM
Rickard Kathleen A.Chief Medical OfficerMay 01, 2022 Option Exercise$0.5256,43229,4862,489,976May 03, 2022, 08:20 PM
Poll ClaireGeneral CounselMay 01, 2022 Option Exercise$0.5279,89641,7461,842,951May 03, 2022, 08:19 PM
Hahn Mark WChief Financial OfficerMay 01, 2022 Option Exercise$0.52432,128225,78715,394,032May 03, 2022, 08:18 PM
ZACCARDELLI DAVIDPresident and CEOMay 01, 2022 Option Exercise$0.52454,864237,66616,384,232May 03, 2022, 08:17 PM
Rickard Kathleen A.Chief Medical OfficerApr 11, 2022 Sale$0.5459,72032,1002,546,408Apr 12, 2022, 04:05 PM
Rickard Kathleen A.Chief Medical OfficerApr 08, 2022 Sale$0.59112,80066,3832,606,128Apr 12, 2022, 04:05 PM
Deschamps LisaDirectorFeb 01, 2022 Sale$0.7811,6649,06970,320Feb 03, 2022, 05:58 PM
Rickard Kathleen A.Chief Medical OfficerFeb 01, 2022 Option Exercise$0.7863,56049,3352,718,928Feb 03, 2022, 05:57 PM
ZACCARDELLI DAVIDPresident and CEOFeb 01, 2022 Option Exercise$0.75334,448250,00017,179,800Feb 03, 2022, 05:56 PM
ZACCARDELLI DAVIDPresident and CEOFeb 01, 2022 Option Exercise$0.78288,648224,07716,891,152Feb 03, 2022, 05:56 PM
ZACCARDELLI DAVIDPresident and CEOFeb 03, 2022 Sale$0.7352,05637,77216,839,096Feb 03, 2022, 05:56 PM
Poll ClaireGeneral CounselFeb 01, 2022 Option Exercise$0.7879,89662,0231,922,847Feb 03, 2022, 05:55 PM
Hahn Mark WChief Financial OfficerFeb 01, 2022 Option Exercise$0.75133,77699,99816,124,896Feb 03, 2022, 05:54 PM
Hahn Mark WChief Financial OfficerFeb 01, 2022 Option Exercise$0.78288,320223,79415,836,576Feb 03, 2022, 05:54 PM
Hahn Mark WChief Financial OfficerFeb 02, 2022 Sale$0.7610,4167,87715,826,160Feb 03, 2022, 05:54 PM
Deschamps LisaDirectorNov 02, 2021 Sale$0.6611,6727,69081,984Nov 03, 2021, 07:53 PM
Rickard Kathleen A.Chief Medical OfficerNov 01, 2021 Option Exercise$0.6456,92836,4342,782,488Nov 03, 2021, 07:53 PM
ZACCARDELLI DAVIDPresident and CEONov 01, 2021 Option Exercise$0.64454,848291,10316,897,408Nov 03, 2021, 07:52 PM
ZACCARDELLI DAVIDPresident and CEONov 02, 2021 Sale$0.6452,05633,37316,845,352Nov 03, 2021, 07:52 PM
Poll ClaireGeneral CounselNov 01, 2021 Option Exercise$0.6479,89651,1332,002,743Nov 03, 2021, 07:51 PM
Hahn Mark WChief Financial OfficerNov 01, 2021 Option Exercise$0.64454,848291,10316,001,536Nov 03, 2021, 07:51 PM
Hahn Mark WChief Financial OfficerNov 02, 2021 Sale$0.6510,4166,72115,991,120Nov 03, 2021, 07:51 PM
ZACCARDELLI DAVIDPresident and CEOAug 03, 2021 Sale$0.7517,65613,28417,352,256Aug 09, 2021, 08:58 PM
ZACCARDELLI DAVIDPresident and CEOAug 01, 2021 Option Exercise$0.79454,848357,05617,404,312Aug 04, 2021, 08:12 PM
ZACCARDELLI DAVIDPresident and CEOAug 04, 2021 Sale$0.7418,40013,67517,369,912Aug 04, 2021, 08:12 PM
ZACCARDELLI DAVIDPresident and CEOAug 03, 2021 Sale$0.7616,00012,21017,388,312Aug 04, 2021, 08:12 PM
Deschamps LisaDirectorAug 01, 2021 Option Exercise$0.7911,6649,15693,656Aug 04, 2021, 07:41 PM
Rickard Kathleen A.Chief Medical OfficerAug 01, 2021 Option Exercise$0.79227,736178,7732,839,416Aug 03, 2021, 10:00 PM
Poll ClaireGeneral CounselAug 01, 2021 Option Exercise$0.79319,600250,8862,443,039Aug 03, 2021, 09:59 PM
Hahn Mark WChief Financial OfficerAug 01, 2021 Option Exercise$0.79454,840357,04916,466,800Aug 03, 2021, 09:45 PM
Hahn Mark WChief Financial OfficerAug 02, 2021 Sale$0.7710,4167,98916,456,384Aug 03, 2021, 09:45 PM
Cunningham KennethDirectorMay 04, 2021 Sale$0.8413,11211,01066,584May 05, 2021, 05:06 PM
Sinha VikasDirectorMay 04, 2021 Sale$0.8410,0168,41074,440May 05, 2021, 05:05 PM
EBSWORTH DAVID RDirectorMay 04, 2021 Sale$0.8411,1849,391684,643May 05, 2021, 05:04 PM
Edwards MartinDirectorMay 04, 2021 Sale$0.8412,02410,097111,064May 05, 2021, 05:04 PM
ZACCARDELLI DAVIDPresident and CEOMay 03, 2021 Option Exercise$0.892,139,6321,898,92317,911,216May 05, 2021, 04:06 PM
ZACCARDELLI DAVIDPresident and CEOMay 04, 2021 Sale$0.8152,05641,92617,859,160May 05, 2021, 04:06 PM
Hahn Mark WChief Financial OfficerMar 01, 2021 Sale$1.1426,72830,57119,054,504Mar 03, 2021, 08:05 PM
ZACCARDELLI DAVIDPresident and CEOMar 01, 2021 Sale$1.1443,39249,62720,050,848Mar 03, 2021, 08:03 PM
Ullman AndersDirectorFeb 01, 2021 Sale$0.9910,80010,733346,912Feb 03, 2021, 07:11 PM
Sinha VikasDirectorFeb 01, 2021 Sale$0.9910,22410,16184,456Feb 03, 2021, 07:11 PM
SHAH MAHENDRADirectorFeb 01, 2021 Sale$0.9910,80010,73383,760Feb 03, 2021, 07:10 PM
Edwards MartinDirectorFeb 01, 2021 Sale$0.9913,68813,603123,088Feb 03, 2021, 07:09 PM
EBSWORTH DAVID RDirectorFeb 01, 2021 Sale$0.9911,91211,838695,827Feb 03, 2021, 07:09 PM
Cunningham KennethDirectorFeb 01, 2021 Sale$0.9913,10413,02379,696Feb 03, 2021, 07:08 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
ZACCARDELLI DAVIDPresident and CEO02/01/20241,101,483
Rickard Kathleen A.Chief Medical Officer02/01/2024166,915
Rickard Kathleen A.Chief Medical Officer02/05/202480,503
Poll ClaireGeneral Counsel02/01/2024237,197
Hahn Mark WChief Financial Officer02/01/20241,102,547
Edwards MartinDirector11/20/202361,973
EBSWORTH DAVID RDirector11/06/2023316,080
Rickard Kathleen A.Chief Medical Officer11/01/2023301,915
Rickard Kathleen A.Chief Medical Officer11/03/2023112,804
Poll ClaireGeneral Counsel11/01/2023303,254
ZACCARDELLI DAVIDPresident and CEO11/01/20231,410,748
Hahn Mark WChief Financial Officer11/01/20231,410,748
Rickard Kathleen A.Chief Medical Officer08/07/20233,949
Rickard Kathleen A.Chief Medical Officer08/04/202369,838
Rickard Kathleen A.Chief Medical Officer08/03/2023128,790
ZACCARDELLI DAVIDPresident and CEO08/03/2023297,754
ZACCARDELLI DAVIDPresident and CEO08/07/202321,263
ZACCARDELLI DAVIDPresident and CEO08/04/2023374,880
Hahn Mark WChief Financial Officer08/07/202321,263
Hahn Mark WChief Financial Officer08/04/2023374,880
Hahn Mark WChief Financial Officer08/03/2023297,754
Poll ClaireGeneral Counsel08/03/202352,324
Poll ClaireGeneral Counsel08/07/20233,731
Poll ClaireGeneral Counsel08/04/202365,859
Hahn Mark WChief Financial Officer08/02/2023191,114
Hahn Mark WChief Financial Officer08/01/2023283,824
Poll ClaireGeneral Counsel08/02/202333,564
Poll ClaireGeneral Counsel08/01/202349,851
ZACCARDELLI DAVIDPresident and CEO08/02/2023191,114
ZACCARDELLI DAVIDPresident and CEO08/01/2023283,824
Rickard Kathleen A.Chief Medical Officer08/02/202335,597
Rickard Kathleen A.Chief Medical Officer08/01/202352,873
ORBIMED ADVISORS LLCDirector05/15/20237,222,484
ORBIMED ADVISORS LLCDirector05/12/2023934,848
ORBIMED ADVISORS LLCDirector05/11/20231,780,800
Gupta RishiDirector05/12/2023934,848
Gupta RishiDirector05/11/20231,780,800
Gupta RishiDirector05/15/20237,222,484
Poll ClaireGeneral Counsel05/01/2023207,041
Rickard Kathleen A.Chief Medical Officer05/03/202376,242
Rickard Kathleen A.Chief Medical Officer05/01/2023199,436
Hahn Mark WChief Financial Officer05/01/20231,173,395
ZACCARDELLI DAVIDPresident and CEO05/01/20231,173,415
Hahn Mark WChief Financial Officer02/01/20231,056,553
ZACCARDELLI DAVIDPresident and CEO02/01/20231,107,083
Rickard Kathleen A.Chief Medical Officer02/02/202372,685
Rickard Kathleen A.Chief Medical Officer02/01/2023230,046
Poll ClaireGeneral Counsel02/01/2023394,273
Poll ClaireGeneral Counsel12/22/2022646,032
ORBIMED ADVISORS LLCDirector12/23/202249,576,607
ORBIMED ADVISORS LLCDirector12/22/202286,424,246
Gupta RishiDirector12/23/202249,576,607
Gupta RishiDirector12/22/202286,424,246
ZACCARDELLI DAVIDPresident and CEO12/20/20221,269,600
Hahn Mark WChief Financial Officer12/20/20221,269,060
ZACCARDELLI DAVIDPresident and CEO11/01/2022727,770
ZACCARDELLI DAVIDPresident and CEO11/01/202255,035
Rickard Kathleen A.Chief Medical Officer11/01/202290,022
Rickard Kathleen A.Chief Medical Officer11/01/202247,125
Hahn Mark WChief Financial Officer11/01/2022727,770
Hahn Mark WChief Financial Officer11/01/202222,011
Access Industries Holdings LLC10% Owner08/15/20226,300,000
ZACCARDELLI DAVIDPresident and CEO08/09/20221,050,000
Hahn Mark WChief Financial Officer08/09/20221,050,000
ZACCARDELLI DAVIDPresident and CEO08/01/2022305,896
ZACCARDELLI DAVIDPresident and CEO08/01/202223,026
Rickard Kathleen A.Chief Medical Officer08/01/202237,951
Rickard Kathleen A.Chief Medical Officer08/02/202220,216
Hahn Mark WChief Financial Officer08/01/2022305,891
Hahn Mark WChief Financial Officer08/01/20229,215
Poll ClaireGeneral Counsel08/01/202253,730
ZACCARDELLI DAVIDPresident and CEO05/03/202216,307
Rickard Kathleen A.Chief Medical Officer05/03/202214,155
Hahn Mark WChief Financial Officer05/03/20226,201
Rickard Kathleen A.Chief Medical Officer05/01/202229,486
Poll ClaireGeneral Counsel05/01/202241,746
Hahn Mark WChief Financial Officer05/01/2022225,787
ZACCARDELLI DAVIDPresident and CEO05/01/2022237,666
Rickard Kathleen A.Chief Medical Officer04/11/202232,100
Rickard Kathleen A.Chief Medical Officer04/08/202266,383
Deschamps LisaDirector02/01/20229,069
Rickard Kathleen A.Chief Medical Officer02/01/202249,335
ZACCARDELLI DAVIDPresident and CEO02/01/2022250,000
ZACCARDELLI DAVIDPresident and CEO02/01/2022224,077
ZACCARDELLI DAVIDPresident and CEO02/03/202237,772
Poll ClaireGeneral Counsel02/01/202262,023
Hahn Mark WChief Financial Officer02/01/202299,998
Hahn Mark WChief Financial Officer02/01/2022223,794
Hahn Mark WChief Financial Officer02/02/20227,877
Deschamps LisaDirector11/02/20217,690
Rickard Kathleen A.Chief Medical Officer11/01/202136,434
ZACCARDELLI DAVIDPresident and CEO11/01/2021291,103
ZACCARDELLI DAVIDPresident and CEO11/02/202133,373
Poll ClaireGeneral Counsel11/01/202151,133
Hahn Mark WChief Financial Officer11/01/2021291,103
Hahn Mark WChief Financial Officer11/02/20216,721
ZACCARDELLI DAVIDPresident and CEO08/03/202113,284
ZACCARDELLI DAVIDPresident and CEO08/01/2021357,056
ZACCARDELLI DAVIDPresident and CEO08/04/202113,675
ZACCARDELLI DAVIDPresident and CEO08/03/202112,210
Deschamps LisaDirector08/01/20219,156
Rickard Kathleen A.Chief Medical Officer08/01/2021178,773
Poll ClaireGeneral Counsel08/01/2021250,886
Hahn Mark WChief Financial Officer08/01/2021357,049
Hahn Mark WChief Financial Officer08/02/20217,989
Cunningham KennethDirector05/04/202111,010
Sinha VikasDirector05/04/20218,410
EBSWORTH DAVID RDirector05/04/20219,391
Edwards MartinDirector05/04/202110,097
ZACCARDELLI DAVIDPresident and CEO05/03/20211,898,923
ZACCARDELLI DAVIDPresident and CEO05/04/202141,926
Hahn Mark WChief Financial Officer03/01/202130,571
ZACCARDELLI DAVIDPresident and CEO03/01/202149,627
Ullman AndersDirector02/01/202110,733
Sinha VikasDirector02/01/202110,161
SHAH MAHENDRADirector02/01/202110,733
Edwards MartinDirector02/01/202113,603
EBSWORTH DAVID RDirector02/01/202111,838
Cunningham KennethDirector02/01/202113,023
Load More Insider Transactions
FUNDS WITH A POSITION IN VERONA PHARMA PLC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
RA CAPITAL MANAGEMENT, L.P.6,317,9901.96%No changeOther
VIVO CAPITAL, LLC4,249,9186.92%No changeOther
ORBIMED ADVISORS LLC3,777,7781.5%No changeOther
MAVERICK CAPITAL LTD1,656,4920.66%NewGrowth At A Reasonable Price, Growth
ADAGE CAPITAL PARTNERS GP, L.L.C.651,9310.03%52.7%Other
BLACKROCK INC.364,6130.00018%8.58%Other
GEODE CAPITAL MANAGEMENT, LLC61,1130.00013%16.43%Other
ALPS ADVISORS INC54,0480.00845%-7.79%Other
UBS OCONNOR LLC48,5330.07%-44.61%Value
CHANGE IN SHARES OUTSTANDING FOR VERONA PHARMA PLC
STOCK BUYBACKS FOR VERONA PHARMA PLC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.62%
1Q
12/31/2023
06/30/2023
1.22%
2Q
12/31/2023
03/31/2023
3.34%
3Q
12/31/2023
09/30/2022
18.03%
5Q
12/31/2023
06/30/2022
32.48%
6Q
12/31/2023
03/31/2022
33.26%
7Q
12/31/2023
09/30/2021
24.51%
9Q
12/31/2023
06/30/2021
36.42%
10Q
12/31/2023
03/31/2021
36.80%
11Q
12/31/2023
09/30/2020
86.26%
13Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0.62%
1Q
06/30/2023
1.22%
2Q
03/31/2023
3.34%
3Q
09/30/2022
18.03%
5Q
06/30/2022
32.48%
6Q
03/31/2022
33.26%
7Q
09/30/2021
24.51%
9Q
06/30/2021
36.42%
10Q
03/31/2021
36.80%
11Q
09/30/2020
86.26%
13Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR VERONA PHARMA PLC
LOADING...